Cargando…

Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease characterized by a thickened non-dilated ventricle in the absence of another cardiac or systemic condition. Its most important hemodynamic consequence is left ventricular outflow tract (LVOT) obstruction. The primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albano, Bernard Benjamin P., Fadreguilan, Erdie C., Chua, Jeffrey M., Ho, James, Medrano, Ana Beatriz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340521/ https://www.ncbi.nlm.nih.gov/pubmed/28275421 http://dx.doi.org/10.14740/cr512w

Ejemplares similares

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)

Conduction system pacing for ventricular pacing requirement is feasible and effective on patients with hypertrophic cardiomyopathy and cardiac dysfunction
por: Jing-jing, Jia, et al.
Publicado: (2023)

Case report of fluoroless ablation in a pregnant patient with atrioventricular reentry tachycardia
por: Fadreguilan, Erdie C, et al.
Publicado: (2022)

Biventricular / Left Ventricular Pacing in Hypertrophic Obstructive Cardiomyopathy: An Overview
por: Vatasescu, Radu, et al.
Publicado: (2012)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Initial Experience of a Cohort of Patients With Hypertrophic Cardiomyopathy Undergoing Biventricular Pacing
por: Rinaldi, Christopher A, et al.
Publicado: (2011)

Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy
por: Arakawa, Yuki, et al.
Publicado: (2020)

Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy
por: Malcolmson, James W., et al.
Publicado: (2022)

Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
por: Gi, Weng-Tein, et al.
Publicado: (2020)

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
por: Chacko, Binita Riya, et al.
Publicado: (2018)

Pacing-associated cardiomyopathy in adult congenital heart disease
por: Moore, Benjamin M, et al.
Publicado: (2020)

Heart transplantation in patients with hypertrophic cardiomyopathy
por: Torres, Marta Farrero, et al.
Publicado: (2018)

Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy
por: Verschure, Derk O., et al.
Publicado: (2015)

Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy
por: Marques, Mayra A., et al.
Publicado: (2021)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Dual Chamber Pacing in a Patient of Hypertrophic Cardiomyopathy with Failure to Wean from Mechanical Ventilator
por: Kanjwal, Shaffi, et al.
Publicado: (2008)

Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials
por: Arnold, Ahran D, et al.
Publicado: (2019)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

Cardiac magnetic resonance as a risk re-stratification tool in apical hypertrophic cardiomyopathy
por: Larriva, Ana María, et al.
Publicado: (2023)

Moderating the Myosin Motor to Treat Hypertrophic Cardiomyopathy
por: Papp, Zoltán
Publicado: (2022)

Cardiomyopathy Induced by Artificial Cardiac Pacing: To Whom, When, Why, and How? Insights on Heart Failure Development
por: Ferrari, Andres Di Leoni, et al.
Publicado: (2023)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2022)

Termination of Ventricular Tachycardia with Antitachycardia Pacing after Ineffective Shock Therapy in an ICD Recipient with Hypertrophic Cardiomyopathy
por: Margos, Panagiotis N, et al.
Publicado: (2009)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―
por: Yoshihisa, Akiomi, et al.
Publicado: (2019)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Cardiovascular magnetic resonance T2* mapping for structural alterations in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2019)

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
por: Melacini, Paola, et al.
Publicado: (2010)

Hypertrophic cardiomyopathy: a heart in need of an energy bar?
por: Vakrou, Styliani, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_20dn8fieuki05a3m1al9ib4r9t